Article
SMN2 and NAIP gene dosages in Vietnamese patients with spinal muscular atrophy.
Pediatrics international : official journal of the Japan Pediatric Society - 1 Jun 2008
Tran Van Khanh, Sasongko Teguh Haryo, Hong Dang Diem, Hoan Nguyen Thi, Dung Vu Chi, Lee Myeong Jin, Gunadi, Takeshima Yasuhiro, Matsuo Masafumi, Nishio Hisahide
Abstract excerpt
BACKGROUND: The SMN1 gene is now recognized as a spinal muscular atrophy (SMA)-causing gene, while SMN2 and NAIP have been characterized as a modifying factor of the clinical severity of SMA. Gene dosage of SMN2 is associated with clinical severity of SMA. But the relationship between gene dosage...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
